New indication positions Repatha as an option for high-risk adults with elevated LDL cholesterol and no prior cardiovascular ...

Eli Lilly's oral GLP-1 receptor agonist Orforglipron showed significant weight loss, A1C reduction, and cardiometabolic ...

Genentech broke ground on a $700 million manufacturing facility in Holly Springs, North Carolina its first on the U.S. East ...

BeOne Medicines entered a deal worth up to $950 million with Royalty Pharma selling its rights to global sales royalties of ...

Pfizer initiates layoffs at its Bothell site as part of a broader cost-cutting strategy, aiming to enhance R&D efficiency and ...

Putnam’s CEO discusses advancements in oncology and how companies are working to ensure patients have access to these new ...

Michael Grosberg, vice president of product management, spoke with Pharmaceutical Executive about direct-to-consumer sales ...

ACOG reaffirms support for COVID-19 vaccines during pregnancy, challenging recent CDC recommendations and emphasizing ...

The FDA suspended Valneva’s U.S. license for its chikungunya vaccine Ixchiq due to serious safety concerns, multiple ...

Michael Grosberg, vice president of product management, spoke with Pharmaceutical Executive about direct-to-consumer sales ...

The collaboration provides BioArctic with an upfront payment of $30 million and potential milestone and royalty payments as ...

The acquisition adds Furoscix, an FDA-approved furosemide infusion therapy for chronic heart failure and kidney disease, ...